|
2016 Journal Article The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease developmentBriskey, David, Tucker, Patrick, Johnson, David W. and Coombes, Jeff S. (2016). The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology, 21 (1), 1-9. doi: 10.1007/s10157-016-1255-y |
|
2016 Journal Article Indoxyl sulphate and kidney disease: causes, consequences and interventionsEllis, Robert J., Small, David M., Vesey, David A., Johnson, David W., Francis, Ross, Vitetta, Luis, Gobe, Glenda C. and Morais, Christudas (2016). Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology, 21 (3), 170-177. doi: 10.1111/nep.12580 |
|
2016 Journal Article Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) studyViecelli, Andrea K., Pascoe, Elaine M., Polkinghorne, Kevan R., Hawley, Carmel M., Paul-Brent, Peta-Anne, Badve, Sunil V., Cass, Alan, Johnson, David W., Kerr, Peter G., Mori, Trevor A., Scaria, Anish, Hooi, Seong L., Ong, Meng L. and Irish, Ashley B. (2016). Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) study. Nephrology, 21 (3), 217-228. doi: 10.1111/nep.12573 |
|
2016 Journal Article Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease: An updateNataatmadja, Melissa, Cho, Yeoungjee, Fahim, Magid and Johnson, David W. (2016). Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease: An update. Reviews on Recent Clinical Trials, 11 (1), 12-32. doi: 10.2174/1574887110666151026123235 |
|
2016 Journal Article Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutionsCho, Yeoungjee, Buchel, Janine, Steppan, Sonja, Passlick-Deetjen, Jutta, Hawley, Carmel M., Dimeski, Goce, Clarke, Margaret and Johnson, David W. (2016). Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions. Peritoneal Dialysis International, 36 (2), 146-153. doi: 10.3747/pdi.2014.00291 |
|
2016 Journal Article Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseJarrett, Rachael, Salio, Mariolina, Lloyd-Lavery, Antonia, Subramaniam, Sumithra, Bourgeois, Elvire, Archer, Charles, Cheung, Ka Lun, Hardman, Clare, Chandler, David, Salimi, Maryam, Gutowska-Owsiak, Danuta, de la Serna, Jorge Bernardino, Fallon, Padraic G., Jolin, Helen, Mckenzie, Andrew, Dziembowski, Andrzej, Podobas, Ewa Izabela, Bal, Wojciech, Johnson, David, Moody, D. Branch, Cerundolo, Vincenzo and Ogg, Graham (2016). Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase. Science Translational Medicine, 8 (325) 325ra18. doi: 10.1126/scitranslmed.aad6833 |
|
2016 Journal Article Focus on peritoneal dialysis training: working to decrease peritonitis ratesZhang, Lei, Hawley, Carmel M. and Johnson, David W. (2016). Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrology Dialysis Transplantation, 31 (2), 214-222. doi: 10.1093/ndt/gfu403 |
|
2016 Conference Publication Developing a set of core outcomes for trials in haemodialysis: an international Delphi surveyEvangelidis, N., Tong, A., Manns, B., Hemmelgarn, B., Wheeler, D., Tugwell, P., Crowe, S., Harris, T., Van Biesen, W., Winkelmayer, W., Sautenet, B., O'Donaghue, D., Tam-Tham, H., Youssouf, S., Mandayam, S., Ju, A., Hawley, C., Pollock, C., Harris, D., Johnson, D., Rifkin, D., Tentori, F., Agar, J., Polkinghorne, K., Gallagher, M., Kerr, P., Mcdonald, S., Howell, M. and Craig, J. (2016). Developing a set of core outcomes for trials in haemodialysis: an international Delphi survey. 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17–21 September 2016. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Journal Article Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunctionCho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2016). Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunction. Peritoneal Dialysis International, 36 (1), 16-25. doi: 10.3747/pdi.2013.00274 |
|
2016 Conference Publication Variation in the Treatment and Prevention of Peritoneal Dialysis Related Infections: Preliminary Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (Pdopps)Perl, Jeffrey, Zhao, Junhui, Bieber, Brian, Robinson, Bruce M., Pisoni, Ronald L., Tentori, Francesca, Davies, Simon J., Kawanishi, Hideki and Johnson, David W. (2016). Variation in the Treatment and Prevention of Peritoneal Dialysis Related Infections: Preliminary Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (Pdopps). 53rd ERA-EDTA Congress, Vienna Austria, May 21-24, 2016. United Kingdom: Oxford University Press. |
|
2016 Conference Publication Inflammation in DialysisDheda, S., Min, H., Van, Eps C., Johnson, D., Vesey, D., Healy, H., Hawley, C. and Fahim, M. (2016). Inflammation in Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17–21 September 2016. Hoboken, NJ United States: Wiley-Blackwell. doi: 10.1111/nep.12887 |
|
2016 Conference Publication Tacrolimus toxicity due to biliary obstruction in a combined kidney and liver transplant recipientChan, S., Burke, M., Johnson, D., Francis, R. and Mudge, D. (2016). Tacrolimus toxicity due to biliary obstruction in a combined kidney and liver transplant recipient. 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17-21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2016 Conference Publication A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the favoured trialViecelli, A., Pascoe, E., Polkinghorne, K., Paul-Brent, P., Darssan, D., Hooi, L., Ong, L., Mori, T., Badve, S., Cass, A., Kerr, P., Voss, D., Hawley, C., Johnson, D. and Irish, A. (2016). A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the favoured trial. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12887 |
|
2016 Book Chapter Aminoglycoside use in patients with chronic kidney diseaseNataatmadja, Melissa, Cho, Yeoungjee, Lloyd, Jess and Johnson, David W. (2016). Aminoglycoside use in patients with chronic kidney disease. Aminoglycosides: pharmacology, clinical uses and health effects. (pp. 53-76) edited by Ruthie Alves. New York, NY, United States: Nova Science Publishers. |
|
2016 Conference Publication Frailty index in chronic kidney disease (FI-CKD) studyChowdhury, R., Peel, N. M., Saweirs, W., Johnson, D., Krosch, M., Senff, S., Basev, A. and Hubbard, R. E. (2016). Frailty index in chronic kidney disease (FI-CKD) study. The Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting 2016, “The AGEnder Paradox”, Cairns, Queensland, Australia, 1–3 June, 2016. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajag.12339 |
|
2016 Book Chapter Complications of peritoneal dialysisKennard, Alice, Johnson, David W. and Hawley, Carmel M. (2016). Complications of peritoneal dialysis. Core concepts in dialysis and continuous therapies. (pp. 121-133) edited by Colm C. Magee, J. Kevin Tucker and Ajay K. Singh. Boston, MA, United States: Springer. doi: 10.1007/978-1-4899-7657-4_10 |
|
2016 Conference Publication Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis PatientsChan, S., Cho, Y., Koh, Y., Boudville, N., Mcdonald, S., Clayton, P., Pascoe, E., Francis, R., Mudge, D., Hawley, C. and Johnson, D. (2016). Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA Australia, 17–21 September 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2016 Conference Publication International Variations in the Experience of Patients On Peritoneal Dialysis (Pd) in the Peritoneal Dialysis Outcomes and Practice Patterns Study (Pdopps)Finkelstein, Fredric O., Zhao, Junhui, Bieber, Brian, Jassal, S. Vanita, Morgenstern, Hal, Tsuchida, Kenji, Brown, Edwina, Johnson, David W. and Tentori, Francesca (2016). International Variations in the Experience of Patients On Peritoneal Dialysis (Pd) in the Peritoneal Dialysis Outcomes and Practice Patterns Study (Pdopps). 53rd ERA-EDTA Congress, Vienna Austria, May 21-24, 2016. United Kingdom: Oxford University Press. |
|
2016 Conference Publication Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signallingOwens, E., Iyer, A., Morais, C., Lohman, R., Suen, J., Johnson, D., Nikolic-Paterson, D., Gobe, G., Fairlie, D. and Vesey, D. (2016). Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signalling. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth Western Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12887 |
|
2016 Conference Publication Randomised Controlled Trial to Determine the Efficacy of Prescribed Fluid Intake to Reduce Progression in Adpkd (Prevent-Adpkd)Wong, A., Allman-Farinelli, M., Erickson, B., Foster, S., Grantham, J., Haloob, I, Harris, D., Hawley, C., Johnson, D., Lee, V, Mai, J., Peduto, A., Rangan, A., Roger, S., Sud, K., Torres, V and Rangan, G. (2016). Randomised Controlled Trial to Determine the Efficacy of Prescribed Fluid Intake to Reduce Progression in Adpkd (Prevent-Adpkd). The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17–21 September 2016. Hoboken, NJ United States: Wiley-Blackwell. |
